Analysts Viewpoint BTIG Research Downgrades MaxCyte Inc (MXCT) to a Neutral from a Buy MaxCyte Inc’s filing revealed that its CHIEF FINANCIAL OFFICER Swirsky Douglas J acquired Company’s shares for reported $64500.0 on Aug
Stock Earnings Insider Buying: Swirsky Douglas J, MaxCyte Inc [MXCT] CHIEF FINANCIAL OFFICER invested 50,000 shares The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or